Active

ANGELINI PHARMA UK-I LIMITED Financials

Company number
13473950Copy
Copy
Registered office
6th Floor Napier House, 24 High Holborn, London WC1V 6AZ
Incorporated
23/06/2021

Company snapshot

Status
Active
Employees
24 (2023)
Latest financial data
2023
Accounts type
Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2023.

Net Assets

£6.29M2023
917.65%vs 2022

2022: £618.16K

Total Assets

£9.13M2023
131.78%vs 2022

2022: £3.94M

Cash in Bank

£2.18M2023
-33.80%vs 2022

2022: £3.29M

Total Liabilities

£2.81M2023
-14.37%vs 2022

2022: £3.29M

Employees

242023
+2vs 2022

2022: 22

In 2023, ANGELINI PHARMA UK-I LIMITED reported net assets of £6.29M. The same filing shows total assets of £9.13M, cash in bank of £2.18M and total liabilities of £2.81M. Reported headcount was 24 in 2023. Net Assets rose from £618.16K in 2022 to £6.29M in 2023 (917.65%). Okredo holds filed figures for 2021–2023; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£6.29M2023
917.65%from £618.16K in 2022

Year-on-year change

Net Assets as filed for 2021–2023. Every figure in this chart is also in the financial history table.

3-year financial trend (2021–2023)

How the figures ANGELINI PHARMA UK-I LIMITED filed moved across the three reported years 2021, 2022 and 2023 — measured end to end rather than year on year.

Net Assets

£293.12K2021£6.29M2023
+2046%vs 2021

+363% a year compound (CAGR)

Cash in Bank

£166.89K2021£2.18M2023
+1206%vs 2021

+261% a year compound (CAGR)

Total Assets

£1.11M2021£9.13M2023
+724%vs 2021

+187% a year compound (CAGR)

Total Liabilities

£815.79K2021£2.81M2023
+245%vs 2021

+85.7% a year compound (CAGR)

Employees

122021242023
+100%vs 2021+12

Biggest increase

Net Assets+2046%

£293.12K in 2021 to £6.29M in 2023

Every indicator Okredo holds for ANGELINI PHARMA UK-I LIMITED rose between 2021 and 2023. The steepest rise came in net assets, pointing to a strengthening balance sheet, with cash in bank, total assets, total liabilities and employee numbers climbing alongside it. See the full year-by-year figures.

Ratios from the filed figures

Calculated from ANGELINI PHARMA UK-I LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
68.87%2023
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
30.81%2023
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
77.46%2023
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
23.87%2023
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for ANGELINI PHARMA UK-I LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator202120222023
Net Assets£293.12K618.16K6.29M
Total Assets£1.11M3.94M9.13M
Cash in Bank£166.89K3.29M2.18M
Total Liabilities£815.79K3.29M2.81M
Employees122224

ANGELINI PHARMA UK-I LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for ANGELINI PHARMA UK-I LIMITED covering 2021–2023, across 5 reported indicators. The most recent reported year is 2023.

ANGELINI PHARMA UK-I LIMITED reported net assets of £6.29M for 2023. That compares with £618.16K in 2022, a change of 917.65%.

ANGELINI PHARMA UK-I LIMITED reported total assets of £9.13M for 2023. That compares with £3.94M in 2022, a change of 131.78%.

ANGELINI PHARMA UK-I LIMITED reported cash in bank of £2.18M for 2023. That compares with £3.29M in 2022, a change of -33.80%.

ANGELINI PHARMA UK-I LIMITED reported 24 employees in 2023, compared with 22 in 2022.

Between 2021 and 2023, ANGELINI PHARMA UK-I LIMITED's net assets rose by 2046%, cash in bank rose by 1206%, total assets rose by 724% and total liabilities rose by 245%. Net assets compounded at 363% a year across the two years to 2023, from £293.12K to £6.29M. Reported headcount went from 12 in 2021 to 24 in 2023 (+12).

Okredo holds reported figures for the years 2021, 2022, 2023. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.